OpenVSafe by OpenVAERS
Search V-safe

7M8-11927-47700

2 vaccinations 7 coded responses 20 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
275 / NC
Registered
2022-07-19
Relationship
Child or adolescent in my care
Guardian
3U8-13692-86957
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-14
    Dose 1 — Pfizer-BioNTech
  2. 2022-07-19
    Registered in v-safe
  3. 2022-07-19
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-20
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-24
    Survey response — day 7, dose 1, under 3
    MedDRA: Dysphonia, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, raspy voice
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-07-29
    Survey response — day 14, dose 1, under 3
    MedDRA: Pyrexia — Feeling: Good
    Free text: Low grade fever
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-08-06
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  8. 2022-08-11
    Survey response — day 28, dose 1, under 3
    MedDRA: Cough, Pyrexia, Rhinorrhoea, Sputum discoloured — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Runny nose, yellow mucus, cough, 102F fever
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-08-11
    Report sent to call center — day 28, dose 1, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  10. 2022-08-12
  11. 2022-08-18
    Health check-in — day 35, dose 1, under 3
    Feeling: Fair
    Under 3 check-in
  12. 2022-08-25
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-09-03
    Dose 2 — Pfizer-BioNTech
  14. 2022-09-06
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Redness · None
    Under 3 check-in
  15. 2022-09-07
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  16. 2022-09-08
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  17. 2022-09-09
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2022-09-13
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-09-17
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2022-09-25
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-10-01
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-10-10
    Survey response — day 35, dose 2, under 3
    MedDRA: Cough — Feeling: Good
    Free text: Cough
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-10-16
    Survey response — day 42, dose 2, under 3
    MedDRA: Cough, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school
    Free text: Postnasal drip, cough- cold weather
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-12-03
    Survey response — 3 months, dose 2, under 3
    MedDRA: Irritability, Pyrexia, Sputum discoloured — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Irritability, fever, yellow mucus
    MedDRA releases: 2024-11 · check-in free text available
  25. 2023-03-06
    Survey response — 6 months, dose 2, under 3
    MedDRA: Exposure to SARS-CoV-2 — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-07-14Pfizer-BioNTech No
22022-09-03Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-08-11 Unsuccessful

Free text

Release 12 (Under 3) — day 7, dose 1, under 3

2022-07-24

Systemic reaction (other): Runny nose, raspy voice

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-29

Symptoms: Low grade fever

Release 12 (Under 3) — day 28, dose 1, under 3

2022-08-11

Symptoms: Runny nose, yellow mucus, cough, 102F fever

Release 12 (Under 3) — day 35, dose 2, under 3

2022-10-10

Symptoms: Cough

Release 12 (Under 3) — day 42, dose 2, under 3

2022-10-16

Symptoms: Postnasal drip, cough- cold weather

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-12-03

Symptoms: Irritability, fever, yellow mucus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDIrritability · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDSputum discoloured · · ✓
SDUpper-airway cough syndrome · · ✓
SRODysphonia · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…